MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer (original) (raw)

• Nowak, A. K., Chow, P. K. & Findlay, M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur. J. Cancer 40, 1474–1484 (2004)
  Article CAS Google Scholar
• Bishop, J. M. Molecular themes in oncogenesis. Cell 64, 235–248 (1991)
  Article CAS Google Scholar
• Felsher, D. W. Cancer revoked: oncogenes as therapeutic targets. Nature Rev. Cancer 3, 375–380 (2003)
  Article ADS CAS Google Scholar
• Jain, M. et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297, 102–104 (2002)
  Article ADS CAS Google Scholar
• Coleman, W. B. Mechanisms of human hepatocarcinogenesis. Curr. Mol. Med. 3, 573–588 (2003)
  Article CAS Google Scholar
• Sandgren, E. P., Quaife, C. J., Pinkert, C. A., Palmiter, R. D. & Brinster, R. L. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4, 715–724 (1989)
  CAS PubMed Google Scholar
• Murakami, H. et al. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res. 53, 1719–1723 (1993)
  CAS PubMed Google Scholar
• Wu, Y. et al. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors. Oncogene 21, 1518–1526 (2002)
  Article CAS Google Scholar
• Simile, M. M. et al. Downregulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 25, 333–334 (2003)
  Article Google Scholar
• Kistner, A. et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl Acad. Sci. USA 93, 10933–10938 (1996)
  Article ADS CAS Google Scholar
• Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199–207 (1999)
  Article CAS Google Scholar
• Venook, A. P. Hepatocellular carcinoma. Curr. Treat. Options Oncol. 1, 407–415 (2000)
  Article CAS Google Scholar
• Thorgeirsson, S. S. Hepatic stem cells in liver regeneration. FASEB J. 10, 1249–1256 (1996)
  Article CAS Google Scholar
• Fausto, N. Hepatocyte differentiation and liver progenitor cells. Curr. Opin. Cell Biol. 2, 1036–1042 (1990)
  Article CAS Google Scholar
• Fausto, N. & Campbell, J. S. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120, 117–130 (2003)
  Article CAS Google Scholar
• Hardy, J. et al. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp. Hematol. 29, 1353–1360 (2001)
  Article CAS Google Scholar
• Uhr, J. W., Tucker, T., May, R. D., Siu, H. & Vitetta, E. S. Cancer dormancy: studies of the murine BCL1 lymphoma. Cancer Res. 51, 5045s–5053s (1991)
  CAS PubMed Google Scholar
• Demicheli, R. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin. Cancer Biol. 11, 297–306 (2001)
  Article CAS Google Scholar
• Naumov, G. N., MacDonald, I. C., Chambers, A. F. & Groom, A. C. Solitary cancer cells as a possible source of tumour dormancy? Semin. Cancer Biol. 11, 271–276 (2001)
  Article CAS Google Scholar
• Uhr, J. W., Scheuermann, R. H., Street, N. E. & Vitetta, E. S. Cancer dormancy: opportunities for new therapeutic approaches. Nature Med. 3, 505–509 (1997)
  Article CAS Google Scholar
• Riethmuller, G. & Klein, C. A. Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin. Cancer Biol. 11, 307–311 (2001)
  Article CAS Google Scholar
• Holmgren, L., O'Reilly, M. S. & Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149–153 (1995)
  Article CAS Google Scholar
• Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105–111 (2001)
  Article ADS CAS Google Scholar
• Willert, K. et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448–452 (2003)
  Article ADS CAS Google Scholar
• Al-Hajj, M. B., Wicha, M. W., Weissman, M. & Clarke, I. M. F. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14, 43–47 (2004)
  Article CAS Google Scholar
• Laird, P. W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197–205 (1995)
  Article CAS Google Scholar
• Lotem, J. & Sachs, L. Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin. Cancer Biol. 12, 339–346 (2002)
  Article CAS Google Scholar
• Leffert, K. S. & Skelly, K. in Cell Culture Methods for Molecular and Cell Biology (eds Barnes, D. W., Sirbasku, D. A. & Sato, G. H.) 43–55 (Alan R. Liss, New York, 1984)
  Google Scholar
• Edinger, M. et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101, 640–648 (2003)
  Article CAS Google Scholar
• Pollack, J. R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 23, 41–46 (1999)
  Article CAS Google Scholar